GREENVILLE, N.C. (WITN) - East Carolina University hosted PharmaFest on Wednesday, giving students a firsthand look at career opportunities in North Carolina’s rapidly expanding pharmaceutical and ...

Federal officials are raising long-standing concerns with research journals and the academic incentive structures propping them up. But experts say the government alone can’t overhaul the industry.

In May 2025, the Trump administration issued an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines” directing the Food and Drug Administration (FDA) and the ...

President Donald Trump‘s proposed 100% tariffs on pharmaceuticals could have a smaller impact than initially expected, thanks to certain loopholes. However, the pharmaceutical industry, particularly ...

President Donald Trump announced his newest round of tariffs set to take effect on Oct. 1 in a series of Truth Social posts Thursday evening. The tariffs will target pharmaceuticals, home goods and ...

Vaccine-maker Moderna has opened a new manufacturing base in Oxfordshire in a boost to the pharmaceutical industry after other major firms shelved or paused planned UK investments this year. The ...

AbbVie is a sector mainstay that had no fewer than 12 drugs with net sales above $1 billion last year. It also paid a generous dividend. Some pharmaceutical companies dream of developing and launching ...

Pfizer PFE0.73%increase; green up pointing triangle has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera MTSR-0.08%decrease; red down pointing triangle in a deal that gets the ...

FIRST ON FOX: Shortly after announcing a strategy to go after deceptive direct-to-consumer advertising by the pharmaceutical industry, Robert F. Kennedy Jr. and the Department of Health and Human ...

TL;DR: Tesla secured a $10 billion order for up to 10,000 Optimus 3+ humanoid robots from PharmAGRI, aiming to restore U.S. drug manufacturing sovereignty. These robots will automate farm operations ...

The Federal Trade Commission (FTC) and Department of Justice Antitrust Division (DOJ) have concluded a series of three listening sessions focused on competition in the pharmaceutical industry. The ...